Two members of Congress from California, Democrat Reps. Ted Lieu and Mark DeSaulnier, are calling for a congressional investigation into manufacturers of opioid painkillers.

Mylan, manufacturer of the allergic reaction treatment EpiPen, has announced it will sell a generic version of the autoinjector at half the price of the branded device after federal lawmakers and consumer groups questioned why its price has gone up 400 percent since Mylan acquired it.

CMS proposed a series of adjustments it intends to strengthen the Affordable Care Act’s insurance exchanges for 2018, including some initiatives insurers have been pushing for, such as pooling high-cost enrollees and adjusting for special enrollment customers. 

The American Academy of Pediatrics (AAP) says states should get rid of laws which allow children to go unvaccinated for diseases like measles for non-medical reasons and advises individual physicians to consider excluding families who continually refuse immunizations from their practice.

Government cuts to state- and federally funded mental healthcare are causing troubles for patients, families and their communities, according to a report by the Boston Globe’s famous investigative Spotlight Team. 

A preliminary analysis of insurer participation on the Affordable Care Act’s insurance exchanges said that 31 percent of counties in the U.S. are likely to have a single insurer marketplace in 2017.

Following the decision by the National Government Services to end its local coverage determination for both cellular and tissue-based products, Organogenesis’s PuraPly and PuraPly Antimicrobial products for wound management will be eligible for Medicare coverage and reimbursement in 10 states.

The FDA has announced that Alere has recalled their INRatio and INRatio2 PT/INR monitoring systems.